Leptin and peroxisome proliferator-activated receptors: Impact on normal and disturbed first trimester human pregnancy

Histology and Histopathology

Volumn 23, Issue 12, 2008, Pages 1465-1475

  Toth, Bettina ^a   Bastug, Mehmet ^a   Scholz, Christoph ^a   Arck, Petra ^b   Schulze, Sandra ^a   Kunze, Susanne ^a   Friese, Klaus ^a   Jeschke, Udo ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

AIB3; Human pregnancy; Hydatidiform mole; Leptin; Miscarriage; PPAR; RXR

Indexed keywords

CYTOKERATIN 7; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINOID X RECEPTOR ALPHA; STEROID RECEPTOR COACTIVATOR 3; LEPTIN RECEPTOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DECIDUA; EPITHELIUM CELL; FEMALE; FETOPLACENTAL UNIT; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDATIDIFORM MOLE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; PLACENTA; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR DOWN REGULATION; SPONTANEOUS ABORTION; TROPHOBLAST; ADULT; BIOSYNTHESIS; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; PREGNANCY; UTERUS CANCER;

ABORTION, SPONTANEOUS; ADULT; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PLACENTA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; RECEPTORS, LEPTIN; RETINOID X RECEPTOR ALPHA; UTERINE NEOPLASMS;

EID: 58149299728     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Barak Y., Nelson M.C., Ong E.S., Jones Y.Z., Ruiz-Lozano P., Chien K.R., Koder A. and Evans R.M. (1999). PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol. Cell. 4, 585-595.
2. Berry E.B., Eykholt R., Helliwell R.J., Gilmour R.S., Mitchell M.D. and Marvin K.W. (2003). Peroxisome proliferator-activated receptor isoform expression changes in human gestational tissues with labor at term. Mol. Pharmacol. 64, 1586-1590.
3. Capparuccia L., Marzioni D., Giordano A., Fazioli F., De Nictolis M., Busso N., Todros T. and Castellucci M. (2002). PPARgamma expression in normal human placenta, hydatidiform mole and choriocarcinoma. Mol. Hum. Reprod 8, 574-579.
4. Castellucci M., De Matteis R., Meisser A., Cancello R., Monsurro V., Islami D., Sarzani R., Marzioni D., Cinti S. and Bischof P. (2000). Leptin modulates extracellular matrix molecules and metalloproteinases: possible implications for trophoblast invasion. Mol. Hum. Reprod. 6, 951-958.
5. Chardonnens D., Cameo P., Aubert M.L., Pralong F.P., Islami D., Campana A., Gaillard R.C. and Bischof P. (1999). Modulation of human cytotrophoblastic leptin secretion by interleukin-1alpha and 17beta-oestradiol and its effect on HCG secretion. Mol. Hum. Reprod. 5, 1077-1082.
6. Dunn-Albanese L.R., Ackerman W.E.T., Xie Y., Iams J.D. and Kniss D.A. (2004). Reciprocal expression of peroxisome proliferator-activated receptor-gamma and cyclooxygenase-2 in human term parturition. Am. J. Obstet. Gynecol. 190, 809-816.
7. El-Bastawissi A.Y., Peters R., Sasseen K., Bell T. and Manolopoulos R. (2007). Effect of the Washington Special Supplemental Nutrition Program for Women, Infants and Children (WIC) on Pregnancy Outcomes. Matern Child Health J.
8. Fournier T., Pavan L., Tarrade A., Schoonjans K., Auwerx J., Rochette-Egly C. and Evain-Brion D. (2002). The role of PPAR-gamma/ RXR-alpha heterodimers in the regulation of human trophoblast invasion. Ann. NY Acad. Sci. 973, 26-30.
9. Fournier T., Handschuh K., Tsatsaris V. and Evain-Brion D. (2007a). Involvement of PPARgamma in human trophoblast invasion. Placenta
10. Fournier T., Tsatsaris V., Handschuh K. and Evain-Brion D. (2007b). PPARs and the placenta. Placenta 28, 65-76.
11. Guettier J.M., Park J.Y., Cochran E.K., Poitou C., Basdevant A., Meier M., Clement K., Magre J. and Gorden P. (2007). Leptin therapy for partial lipodystrophy linked to a PPAR-gamma mutation. Clin. Endocrinol. (Oxf).
12. Hauguel-de Mouzon S., Lepercq J. and Catalano P. (2006). The known and unknown of leptin in pregnancy. Am. J. Obstet. Gynecol. 194, 1537-1545.
13. Hong S.E., Ahn I.S., Jung H.S., Rayner D.V. and Do M.S. (2004). Effect of retinoic acid on leptin, glycerol, and glucose levels in mature rat adipocytes in vitro. J. Med. Food 7, 320-326.
14. Jawerbaum A., Capobianco E., Pustovrh C., White V., Baier M., Salzberg S., Pesaresi M. and Gonzalez E. (2004). Influence of peroxisome proliferator-activated receptor gamma activation by its endogenous ligand 15-deoxy Delta12,14 prostaglandin J2 on nitric oxide production in term placental tissues from diabetic women. Mol. Hum. Reprod. 10, 671-676.
15. Jiang C., Ting A.T. and Seed B. (1998). PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391, 82-86.
16. Kuang S.Q., Liao L., Zhang H., Pereira F.A., Yuan Y., DeMayo F.J., Ko L. and Xu J. (2002). Deletion of the cancer-amplified coactivator AIB3 results in defective placentation and embryonic lethality. J. Biol. Chem. 277, 45356-60.
17. Lage M., Garcia-Mayor R.V., Tome M.A., Cordido F., Valle-Inclan F., Considine R.V., Caro J.F., Dieguez C. and Casanueva F.F. (1999). Serum leptin levels in women throughout pregnancy and the postpartum period and in women suffering spontaneous abortion. Clin. Endocrinol. (Oxf) 50, 211-216.
18. Laird S.M., Quinton N.D., Anstie B., Li T.C. and Blakemore A.I. (2001). Leptin and leptin-binding activity in women with recurrent miscarriage: correlation with pregnancy outcome. Hum. Reprod. 16, 2008-2013.
19. Lambrinoudaki I.V., Christodoulakos G.E., Economou E.V., Vlachou S.A., Panoulis C.P., Alexandrou A.P., Kouskouni E.E. and Creatsas G.C. (2008). Circulating leptin and ghrelin are differentially influenced by estrogen/ progestin therapy and raloxifene. Maturitas 59, 62-71.
20. Lappas M., Permezel M. and Rice G.E. (2005). Leptin and adiponectin stimulate the release of proinflammatory cytokines and prostaglandins from human placenta and maternal adipose tissue via nuclear factor-kappaB, peroxisomal proliferator-activated receptor-gamma and extracellularly regulated kinase 1/2. Endocrinology 146, 3334-3442.
21. Lappas M., Permezel M. and Rice G.E. (2006). 15-Deoxy-Delta(12,14)-prostaglandin J(2) and troglitazone regulation of the release of phospholipid metabolites, inflammatory cytokines and proteases from human gestational tissues. Placenta 27, 1060-1072.
22. Lappas M., Yee K., Permezel M. and Rice G.E. (2005). Release and regulation of leptin, resistin and adiponectin from human placenta, fetal membranes, and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellitus-complicated pregnancies. J. Endocrinol. 186, 457-65.
23. Lee J.I., Paik Y.H., Lee K.S., Lee J.W., Kim Y.S., Jeong S., Kwon K.S., Lee D.H., Kim H.G., Shin Y.W. and Kim M.A. (2007). A peroxisome-proliferator activated receptor-gamma ligand could regulate the expression of leptin receptor on human hepatic stellate cells. Histochem. Cell Biol. 127, 495-502.
24. Lepercq J. and Hauguel De Mouzo S. (2002). [Leptin during pregnancy]. J. Gynecol. Obstet. Biol. Reprod. (Paris) 31, 167-172.
25. Li R.H., Yu M.M., Cheung A.N. and Wong Y.F. (2004). Expression of leptin and leptin receptors in gestational trophoblastic diseases. Gynecol. Oncol. 95, 299-306.
26. Muhlhausler B.S., Duffield J.A. and McMillen I.C. (2007). Increased maternal nutrition stimulates peroxisome proliferator activated receptor-gamma, adiponectin, and leptin messenger ribonucleic acid expression in adipose tissue before birth. Endocrinology 148, 878-885.
27. Paracchini V., Pedotti P. and Taioli E. (2005). Genetics of leptin and obesity: a HuGE review. Am. J. Epidemiol. 162, 101-114.
28. Rai R. and Regan L. (2006). Recurrent miscarriage. Lancet 368, 601-11.
29. Regan L. and Rai R. (2000). Epidemiology and the medical causes of miscarriage. Baillieres Best Pract Res Clin. Obstet. Gynaecol. 14, 839-854.
30. Remmele W. and Stegner H.E. (1987). Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8, 138-140.
31. Ricote M., Huang J.T., Welch J.S. and Glass C.K. (1999). The peroxisome proliferator-activated receptor(PPARgamma) as a regulator of monocyte/ macrophage function. J. Leukoc. Biol. 66, 733-739.
32. Rodie V.A., Young A., Jordan F., Sattar N., Greer I.A. and Freeman D.J. (2005). Human placental peroxisome proliferator-activated receptor delta and gamma expression in healthy pregnancy and in preeclampsia and intrauterine growth restriction. J. Soc. Gynecol. Investig. 12, 320-329.
33. Schaiff W.T., Barak Y. and Sadovsky Y. (2006). The pleiotropic function of PPAR gamma in the placenta. Mol. Cell Endocrinol. 249, 10-15.
34. Schaiff W.T., Carlson M.G., Smith S.D., Levy R., Nelson D.M. and Sadovsky Y. (2000). Peroxisome proliferator-activated receptor-gamma modulates differentiation of human trophoblast in a ligand-specific manner. J. Clin. Endocrinol. Metab. 85, 3874-3881.
35. Schild R.L., Schaiff W.T., Carlson M.G., Cronbach E.J., Nelson D.M. and Sadovsky Y. (2002). The activity of PPAR gamma in primary human trophoblasts is enhanced by oxidized lipids. J. Clin. Endocrinol. Metab. 87, 1105-1110.
36. Tarrade A., Schoonjans K., Guibourdenche J., Bidart J.M., Vidaud M., Auwerx J., Rochette-Egly C. and Evain-Brion D. (2001). PPAR gamma/RXR alpha heterodimers are involved in human CG beta synthesis and human trophoblast differentiation. Endocrinology 142, 4504-4514.
37. Tarrade A., Schoonjans K., Pavan L., Auwerx J., Rochette-Egly C., Evain-Brion D. and Fournier T. (2001). PPARgamma/RXRalpha heterodimers control human trophoblast invasion. J. Clin. Endocrinol. Metab. 86, 5017-5024.
38. Tommaselli G.A., Di Spiezio Sardo A., Di Carlo C., Bifulco G., Cerrota G., Cirillo D., Greco E. and Nappi C. (2006). Do serum leptin levels have a role in the prediction of pregnancy outcome in case of threatened miscarriage? Clin. Endocrinol. (Oxf) 65, 772-775.
39. Tontonoz P., Hu E. and Spiegelman B.M. (1994). Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 79, 1147-1156.
40. Toth B., Hornung D., Scholz C., Djalali S., Friese K. and Jeschke U. (2007). Peroxisome proliferator-activated receptors: new players in the field of reproduction. Am. J. Reprod. Immunol. 58, 289-310.
41. Wang Q., Fujii H. and Knipp G.T. (2002). Expression of PPAR and RXR isoforms in the developing rat and human term placentas. Placenta 23, 661-671.
42. Wendling O., Chambon P. and Mark M. (1999). Retinoid X receptors are essential for early mouse development and placentogenesis. Proc. Natl. Acad. Sci. USA 96, 547-551.